Headquarters: New York, NY
Investor Relations: Zach Herschfus / +1-844-9-ORAMED / zach@oramed.com

Description
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801.
Industry
Life Sciences
Year Founded
Website
Ownership
Public
Exchange / Symbol
NASDAQ: ORMP